Table 1. Changes in dependent variables at pre and post exercise intervention for continuous moderate intensity group.
| Continuous low-moderate intensity training group | Low-volume high-intensity training group | Between group comparisons | |||||
|---|---|---|---|---|---|---|---|
| Variable | Pre (n = 8) SD | Post (n = 8) SD | % change (95% CI) | Pre (n = 8) SD | Post (n = 8) SD | % change (95% CI) | Partial Eta Squared |
| Hip (cm) | 104.69 ± 10.40 | 101.63 ± 9.43 | −2.75% (−6.30–0.80) | 110.45 ±10.94 | 104.38 ± 8.45 | −5.22% (−9.01–1.44) | 0.11d |
| Waist (cm) | 90.31 ± 12.66 | 87.69 ± 10.15 | −2.62% (−4.82–0.42) | 93.5 ± 13.03 | 86.95 ± 9.78 | −6.64% (−9.92–3.36) | 0.32d |
| RHR (BPM) | 75.63 ± 11.82 | 71.75 ± 8.51 | −3.54% (−14.22–7.14) | 74.75 ± 16.02 | 73.13 ± 14.81 | −1.07% (−18.46–20.60) | 0.20d |
| SBP (mmHg) | 127.5 ± 8.77 | 126.50 ± 7.75 | −0.39% (−6.70–5.93) | b129.86 ± 10.85 | b122.14 ± 10.81 | −5.78% (−9.94- -2.63) | 0.46d |
| DBP (mmHg) | 78.5 ± 10.21 | 83.25 ± 4.43 | 7.90% (−4.26–20.06) | 84.5 ± 10.50 | 78.75 ± 71.78 | −6.12% (−13.63–1.39) | 0.67d |
| STS (5) (s) | 9.32 ± 3.07 | 8.67 ± 2.81 | −6.39% (−13.18–0.40) | 10.23 ± 2.97 | 7.74 ± 2.31 | −23.46% (−32.31–14.61) | 0.06d |
| 6MWT (m) | 520.88 ± 74.25 | 530.56 ± 107.81 | 1.16% (−3.85–6.17) | 502.81 ± 148.53 | 577.25 ± 102.55 | 18.53% (7.01–30.06) | 0.50c |
| Mass (kg) | 65.15± 8.69 | 65.14 ± 8.96 | −0.06% (−1.03–0.91) | 75.83 ± 11.58 | 74.01 ± 11.55 | −2.43% (−4.08–0.78) | 0.01 |
| Fat % | 42.11 ± 6.62 | 41.34 ± 7.80 | −2.20% (−7.61–3.22) | 43.28 ± 8.10 | 43.23 ± 6.79 | −0.88% (−6.97–8.73) | 0.03 |
| Fat (kg) | 26.31 ± 7.32 | 26.38 ± 7.61 | 0.29% (−3.71–4.29) | 32.17 ± 9.55 | 30.57± 9.63 | −5.50% (−9.61–1.39) | 0.004 |
| Lean (kg) | 36.55 ± 4.80 | 36.49 ± 4.10 | −0.09% (−1.96–2.15) | 40.90 ± 5.27 | 40.88 ± 4.90 | 0.09% (−2.30–2.49) | 0.22d |
| FBGL (mmol/L) | 4.99 ± .50 | 4.93 ± .74 | −1.41% (−8.12–5.29) | 4.85 ± 0.22 | 4.73 ± 0.49 | −2.40% (−10.18–5.39) | 0.01 |
| CRP (mg/L) | a1.5 ± 084 | a2.00 ± 1.67 | 19.44% (−1.75–40.64) | b2.14 ± 1.21 | b1.71 ± 0.95 | −5.95% (−43.18–31.28) | 0.51 |
| Insulin (mU/L) | b8.76 ± 3.07 | b8.29 ± 3.07 | −0.98% (−24.12–26.07) | a8.30 ± 0.87 | a6.32 ± 1.11 | −24.09% (−30.52–17.65) | 0.28 |
| WBC (x10 9/L) | b5.09 ± 1.95 | b5.26 ± 1.59 | 1.05% (−2.69–4.79) | 7.30 ± 3.07 | 7.59 ± 3.00 | 5.23% (−1.64–12.10) | 0.23 |
| PWV (m/s) | 6.51 ± 1.84 | 6.24 ± 1.11 | −8.03% (−30.43–46.50) | a6.1625 ± 1.95 | a6.46 ± 1.34 | 8.93% (−14.51–32.37) | 0.55d |
| MAP (mmHg) | 101.50 ± 10.35 | 99.13 ± 6.45 | −1.51% (−9.80–6.78) | 102.25 ± 15.69 | 92.50 ± 8.19 | −8.59% (−14.61–2.56) | 0.58d |
| CSP (mmHg) | 123.38 ± 13.43 | 117.5 ± 8.83 | −3.80% (−12.98–5.38) | 128.37 ± 25.13 | 111.13 ± 4.41 | −12.29% (−17.89–6.68) | 0.61d |
| PP (mmHg) | 35.63 ± 8.11 | 32.88 ± 5.69 | −5.31% (−19.00–8.38) | 42.38 ± 17.07 | 32.00 ± 7.29 | −20.34% (−29.98–10.70) | 0.52d |
| AP (mmHg) | 8.50 ± 5.26 | 6.00 ± 5.26 | −4.06% (−57.66–49.53) | 10.38 ± 8.94 | 6.25 ± 5.65 | −97.63% (−215.63–21.50) | 0.10d |
| AIx (%) | 22.13 ± 12.56 | 17.00 ± 15.65 | −124.12% (−124.69–372.93) | 23.25 ± 14.71 | 17.38 ± 14.74 | −124.36% (−319.66–70.95) | 0.05 |
| CDP (mmHg) | 86.88 ± 3.05 | 84.63 ± 4.31 | −1.72% (−9.74–6.30) | 87.38 ± 11.72 | 79.13 ± 8.17 | −8.76% (−14.93–2.58) | 0.61d |
| FACTG | 81.25 ± 9.45 | 85.88 ± 7.38 | 6.14% (1.84–10.45) | 77.63 ± 13.59 | 89.50 ± 6.82 | 17.44% (6.65–28.23) | 0.20d |
Notes.
a
n = 6 participants.
b
n = 7 participants.
c
group × time effect.
d
time effect.